Generate Biomedicines Overview
Generate Biomedicines (GENB) has a P/E ratio of -2.88, below the sector sector average of 47.3.
Get informed when a big investor buys or sells
+ Follow-2.88
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, GENB shows a P/E ratio of -2.88. That is below the sector sector average of 47.3. Scroll down for historical charts and peer comparison views.
The its sector sector average P/E ratio is about 47.3. Generate Biomedicines is at -2.88, which is lower that average. That is roughly 106.1% below the sector mean. Use the comparison chart on this page to see how GENB stacks up against individual peers as well.
Investors watch GENB's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Generate Biomedicines's latest reading is -2.88. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Generate Biomedicines's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -2.88) with ownership activity and broader fundamentals.
